Total Payments
$20,025
2024 Payments
$376.25
Companies
18
Transactions
37
Medicare Patients
328
Medicare Billing
$25,873
Payment Breakdown by Category
Research$16,250 (81.1%)
Food & Beverage$2,188 (10.9%)
Travel$1,587 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $16,250 | 7 | 81.1% |
| Food and Beverage | $2,188 | 28 | 10.9% |
| Travel and Lodging | $1,587 | 2 | 7.9% |
Payments by Type
Research
$16,250
7 transactions
General
$3,775
30 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $16,250 | 7 | $0 (2022) |
| RefleXion Medical, Inc. | $2,043 | 5 | $0 (2023) |
| Medtronic, Inc. | $377.65 | 3 | $0 (2024) |
| Integra LifeSciences Corporation | $204.81 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $203.24 | 3 | $0 (2022) |
| Zimmer Biomet Holdings, Inc. | $184.36 | 2 | $0 (2021) |
| Stryker Corporation | $143.01 | 3 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $133.65 | 1 | $0 (2023) |
| Novocure Inc. | $107.97 | 1 | $0 (2018) |
| Medrobotics Inc. | $101.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $376.25 | 5 | Integra LifeSciences Corporation ($204.81) |
| 2023 | $2,232 | 8 | RefleXion Medical, Inc. ($2,043) |
| 2022 | $9,926 | 6 | Regeneron Pharmaceuticals, Inc. ($9,750) |
| 2021 | $6,887 | 7 | Regeneron Pharmaceuticals, Inc. ($6,500) |
| 2019 | $186.11 | 2 | Zimmer Biomet Holdings, Inc. ($122.76) |
| 2018 | $252.16 | 4 | Novocure Inc. ($107.97) |
| 2017 | $165.66 | 5 | Stryker Corporation ($143.01) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Medtronic, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $119.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/31/2024 | Abbott Laboratories | ALINITY M (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Molecular Diagnostics | ||||||
| 07/11/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device), INSPIRA AIR, RELIEVA SPINPLUS NAV | Food and Beverage | In-kind items and services | $76.52 | General |
| Category: ENT | ||||||
| 07/02/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device), INSPIRA AIR, RELIEVA SPINPLUS NAV | Food and Beverage | In-kind items and services | $128.29 | General |
| Category: ENT | ||||||
| 03/12/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $29.18 | General |
| Category: Wound Care | ||||||
| 12/06/2023 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $793.42 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 12/05/2023 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Food and Beverage | In-kind items and services | $157.27 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 11/15/2023 | Coastal Medical Technologies LLC | — | Food and Beverage | In-kind items and services | $25.27 | General |
| 10/06/2023 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $793.42 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 10/05/2023 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Food and Beverage | In-kind items and services | $157.27 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 05/08/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $133.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/24/2023 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Food and Beverage | In-kind items and services | $141.47 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 06/13/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $750.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 06/06/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 05/31/2022 | Janssen Biotech, Inc. | DARZALEX (Biological), ERLEADA | Food and Beverage | In-kind items and services | $47.90 | General |
| Category: Oncology | ||||||
| 05/23/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 05/10/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 01/12/2022 | Medtronic, Inc. | SITUATE (Device) | Food and Beverage | In-kind items and services | $128.59 | General |
| Category: OR Safety | ||||||
| 12/17/2021 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $6,000.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 12/13/2021 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | Cash or cash equivalent | $250.00 | Research |
| Study: A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) • Category: ONCOLOGY | ||||||
| 11/10/2021 | Janssen Biotech, Inc. | DARZALEX (Biological), ERLEADA | Food and Beverage | In-kind items and services | $135.78 | General |
| Category: Oncology | ||||||
| 09/24/2021 | Zimmer Biomet Holdings, Inc. | Connected Health-None (Device) | Food and Beverage | In-kind items and services | $61.60 | General |
| Category: Connected Health | ||||||
| 06/23/2021 | Medtronic, Inc. | Situate (Device) | Food and Beverage | In-kind items and services | $129.22 | General |
| Category: OR Safety | ||||||
| 05/16/2021 | DePuy Synthes Sales Inc. | TRUMATCH (Device) | Food and Beverage | In-kind items and services | $60.37 | General |
| Category: Ortho-Knee | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2 STUDY OF NEOADJUVANT CEMIPLIMAB FOR STAGE II TO IV (M0) CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) | Regeneron Pharmaceuticals, Inc. | $16,250 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 93 | 112 | $34,569 | $7,716 |
| 2022 | 3 | 57 | 70 | $16,290 | $3,599 |
| 2021 | 5 | 101 | 127 | $37,447 | $9,694 |
| 2020 | 3 | 77 | 100 | $22,859 | $4,865 |
Total Patients
328
Total Services
409
Medicare Billing
$25,873
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 29 | 37 | $13,850 | $1,925 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 26 | $6,230 | $1,794 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $5,915 | $1,655 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $5,054 | $1,257 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 22 | $3,520 | $1,086 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 22 | 27 | $6,345 | $1,774 | 28.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 16 | 21 | $6,425 | $914.40 | 14.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 22 | $3,520 | $910.18 | 25.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 25 | 25 | $9,175 | $2,403 | 26.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 15 | 15 | $6,825 | $2,262 | 33.1% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2021 | 26 | 40 | $12,352 | $1,967 | 15.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 21 | $4,935 | $1,692 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 19 | 26 | $4,160 | $1,370 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 32 | $7,640 | $1,970 | 25.8% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2020 | 24 | 31 | $8,915 | $1,531 | 17.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 37 | $6,304 | $1,363 | 21.6% |
About Dr. Brian Moore, MD
Dr. Brian Moore, MD is a Otolaryngology healthcare provider based in Eglin Afb, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548248552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Moore, MD has received a total of $20,025 in payments from pharmaceutical and medical device companies, with $376.25 received in 2024. These payments were reported across 37 transactions from 18 companies. The most common payment nature is "" ($16,250).
As a Medicare-enrolled provider, Moore has provided services to 328 Medicare beneficiaries, totaling 409 services with total Medicare billing of $25,873. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Plastic Surgery within the Head & Neck
- Location Eglin Afb, FL
- Active Since 01/09/2006
- Last Updated 09/03/2009
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1548248552
Products in Payments
- LIBTAYO (Biological) $16,250
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $2,043
- ACCLARENT AERA (Device) $204.81
- DARZALEX (Biological) $183.68
- DUPIXENT (Biological) $133.65
- Situate (Device) $129.22
- SITUATE (Device) $128.59
- Traumaone (Device) $122.76
- PROPEL (Device) $119.84
- Oncology (Device) $107.97
- Hybrid MMF (Device) $79.23
- 1588 HD 3 Chip Camera (Device) $63.78
- Connected Health-None (Device) $61.60
- TRUMATCH (Device) $60.37
- Enhertu (Drug) $29.91
- Kerecis Omega3 SurgiClose (Device) $29.18
- AxoGuard Nerve Protector (Device) $23.38
- OFIRMEV (Drug) $22.65
- ALINITY M (Device) $22.42
- Tremfya (Drug) $19.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.